Cargando…
Low expression of ZHX3 is associated with progression and poor prognosis in colorectal cancer
Accumulating studies suggest that ZHX3, the member of ZHX family, is involved in a variety of biological functions such as development and differentiation. Recently, ZHX3 may also be involved in the progression of several cancer types including renal cancer, gastric cancer, liver cancer and breast c...
Autores principales: | Cai, Zhai, Wang, Songsheng, Zhou, Huabin, Cao, Ding |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656720/ https://www.ncbi.nlm.nih.gov/pubmed/37979559 http://dx.doi.org/10.1016/j.tranon.2023.101829 |
Ejemplares similares
-
Low expression of ZHX1 and ZHX2 impacts on the prognosis of chronic lymphocytic leukemia
por: Maciel, Natália Ioseph Gladistone, et al.
Publicado: (2021) -
Upregulation of ZHX2 predicts poor prognosis and is correlated with immune infiltration in gastric cancer
por: Cheng, Anqi, et al.
Publicado: (2021) -
Attenuated ZHX3 expression is predictive of poor outcome for liver cancer: Indication for personalized therapy
por: You, Yanjie, et al.
Publicado: (2022) -
ZHX2 in health and disease
por: Li, Na, et al.
Publicado: (2022) -
Attenuated ZHX3 expression serves as a potential biomarker that predicts poor clinical outcomes in breast cancer patients
por: You, Yanjie, et al.
Publicado: (2019)